mIF (DNA, CD3, CD8 and CD57) was used to determine the abundance and diversity of the four subsets of T cells in 102 MCL patients in tumor-rich and tumor-sparse regions, respectively (Figure 2A, Supplementary Materials Figure S2A). This evidence concerns the gene B3GAT1 and neoplasm.